The U.S. Consulate in Düsseldorf, Germany will host a VIP Event involving BioPortUSA and EY Life Sciences on November 17th. The presentation titled “Demystifing US Market Entry” will focus on what the international medical device community needs to take into consideration when contemplating market entry into the US healthcare market. The event is slated to take place one day before the start of MEDICA, the worlds largest medical device show
In addition to Mark Lesselroth, BioPortUSA’s CEO, General Counsel David Reed and FDA specialist Rob Packard will be presenting alongside Peter Behner from EY. “We are very excited to have EY join BioPortUSA at our event, and are honored to have Peter who leads EY’s Global Life Science Transaction Division present about the current healthcare trends in the USA.” Whether you are thinking about market entry or you are doing business in the USA already, there are many different factors to consider if you want to be successful. This event will touch on the top 10 things companies should be thinking of before venturing into the largest healthcare market in the world.
Download a PDF of the flyer announcing The U.S. Consulate in Düsseldorf, VIP Event with BioPortUSA and EY Life Sciences on November 17th here.